907 results on '"Kalra, Philip"'
Search Results
2. Evaluation of a proteomic signature coupled with the kidney failure risk equation in predicting end stage kidney disease in a chronic kidney disease cohort
3. Correction: Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry
4. Multivariate canonical correlation analysis identifies additional genetic variants for chronic kidney disease
5. The development and internal pilot trial of a digital physical activity and emotional well-being intervention (Kidney BEAM) for people with chronic kidney disease
6. Exploring How the Kidney BEAM Physical Activity Digital Health Intervention Improved Mental Health-Related Quality of Life for People Living With Kidney Disease
7. Kidney Beam-A Cost-Effective Digital Intervention to Improve Mental Health
8. The epidemiology of primary FSGS including cluster analysis over a 20-year period
9. Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry
10. Evaluating the effect of a digital health intervention to enhance physical activity in people with chronic kidney disease (Kidney BEAM): a multicentre, randomised controlled trial in the UK
11. Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
12. An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial
13. A Randomized Trial of Intravenous Iron Supplementation and Exercise on Exercise Capacity in Iron-Deficient Nonanemic Patients With CKD
14. Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients
15. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442–1451
16. Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Kidney Int Rep. 2018;3:625–637
17. Managing acute presentations of atheromatous renal artery stenosis
18. Analysis of oxidative stress, inflammation and endothelial function following intravenous iron in chronic kidney disease in the Iron and Heart Trial
19. The effect of intravenous iron supplementation on exercise capacity in iron-deficient but not anaemic patients with chronic kidney disease: study design and baseline data for a multicentre prospective double-blind randomised controlled trial
20. Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?
21. Post-Transplant Cardiovascular Disease in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes in the Era of Modern Immunosuppression
22. Randomized Trial—PrEscription of intraDialytic exercise to improve quAlity of Life in Patients Receiving Hemodialysis
23. Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron Therapy
24. Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
25. Membranoproliferative Glomerulonephritis over 20 Years at a Tertiary Referral Center in the UK
26. An Eye to the Future: Development of a Metabolic-Renal-Cardiac (MRC) Service: PUB256
27. Risk of ESKD and Incidence of New-Onset Major Adverse Cardiovascular Events in a Large, Deprived Population With Type 2 Diabetes Mellitus: PUB101
28. Revolutionising outpatient clinic experience (RevOCE): the future of chronic kidney disease care and associated multimorbidity
29. Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy
30. Association of deprivation and its individual domains on outcomes in people with chronic kidney disease
31. Incidence, Risk Factors, and Outcomes of De Novo Malignancy following Kidney Transplantation
32. Associations with baseline Blood Pressure Control in the NURTuRE-CKD
33. Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
34. Adverse outcomes associated with rapid linear and non-linear patterns of chronic kidney disease progression
35. A validation study of the 4-variable and 8-variable kidney failure risk equation in transplant recipients in the United Kingdom
36. Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney disease
37. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility
38. Community- versus hospital-acquired acute kidney injury in hospitalised COVID-19 patients
39. Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom
40. A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism
41. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
42. Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease
43. THE PREDICTIVE ROLE OF SYMPTOMS IN COVID-19 DIAGNOSTIC MODELS – A LONGITUDINAL INSIGHT
44. Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohort
45. Mechanistic Links between Central Obesity and Cardiorenal Metabolic Diseases
46. Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C study.
47. Antihypertensive prescribing patterns in non-dialysis dependent chronic kidney disease: Findings from the Salford Kidney Study
48. 2363. Three-Month Safety and Immunogenicity of Bivalent SARS-CoV-2 Omicron-Containing Booster Vaccines: Interim Results From a Phase 3, Randomized, Observer-Blind, Active-Controlled Trial
49. Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe
50. Risk Factors for Prognosis in Patients With Severely Decreased GFR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.